Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Effect of Undenatured Cysteine-Rich Whey Protein Isolate (HMS 90®) in Patients With Parkinson's Disease: Changes in Biomarkers of Oxidative Stress, Profiles of Plasma Amino Acids and Their Derivatives and Brain Function

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT01662414
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:35:37.264648+00:00
Published At
2013-09-30T00:00:00+00:00
Record Updated At
2013-09-30
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Parkinson Disease", "Parkinsonian Disorders", "Basal Ganglia Diseases", "Brain Diseases", "Central Nervous System Diseases", "Nervous System Diseases", "Movement Disorders", "Neurodegenerative Diseases"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2013-09-30"
protocolSection.identificationModule.nctId
"NCT01662414"
protocolSection.identificationModule.officialTitle
"Effect of Undenatured Cysteine-Rich Whey Protein Isolate (HMS 90\u00ae) in Patients With Parkinson\u0027s Disease: Changes in Biomarkers of Oxidative Stress, Profiles of Plasma Amino Acids and Their Derivatives and Brain Function"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE4"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Parkinson Disease (protocolSection.conditionsModule.conditions)
  • Parkinsonian Disorders (protocolSection.conditionsModule.conditions)
  • Basal Ganglia Diseases (protocolSection.conditionsModule.conditions)
  • Brain Diseases (protocolSection.conditionsModule.conditions)
  • Central Nervous System Diseases (protocolSection.conditionsModule.conditions)
  • Nervous System Diseases (protocolSection.conditionsModule.conditions)
  • Movement Disorders (protocolSection.conditionsModule.conditions)
  • Neurodegenerative Diseases (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.